Update in lean metabolic dysfunction-associated steatotic liver disease
CONCLUSION: MASLD is a complex disease comprising epigenetic, genetic, and metabolic factors in its pathogenesis. Results vary across populations, gender, and age. Limited data exists on clinical practice guidelines for lean patients. Future studies employing this new nomenclature can contribute to standardizing and generalizing results among lean patients with steatotic liver disease.PMID:38577539 | PMC:PMC10989317 | DOI:10.4254/wjh.v16.i3.452 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Karina Sato-Espinoza Perapa Chotiprasidhi Mariella R Huaman Javier D íaz-Ferrer Source Type: research

Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
CONCLUSION: Hepatic steatosis lowers the biochemical response to antiviral treatment in patients with CHB.PMID:38577526 | PMC:PMC10989305 | DOI:10.4254/wjh.v16.i3.465 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Shi-Yi Liu Dian Wang Jing Liu Lu-Ping Yang Gong-Ying Chen Source Type: research

Non-alcoholic fatty liver disease and sleep disorders
World J Hepatol. 2024 Mar 27;16(3):304-315. doi: 10.4254/wjh.v16.i3.304.ABSTRACTStudies have shown that non-alcoholic fatty liver disease (NAFLD) may be associated with sleep disorders. In order to explore the explicit relationship between the two, we systematically reviewed the effects of sleep disorders, especially obstructive sleep apnea (OSA), on the incidence of NAFLD, and analyzed the possible mechanisms after adjusting for confounding factors. NAFLD is independently associated with sleep disorders. Different sleep disorders may be the cause of the onset and aggravation of NAFLD. An excessive or insufficient sleep du...
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Lu-Fang Bu Chong-Yu Xiong Jie-Yi Zhong Yan Xiong Dong-Ming Li Fen-Fang Hong Shu-Long Yang Source Type: research

Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019)
CONCLUSION: Increasing age and male sex link NAFLD with adverse MACCE outcomes; Native Americans and Asian Pacific Islanders face higher mortality, highlighting a need for tailored interventions and care.PMID:38576521 | PMC:PMC10989223 | DOI:10.4330/wjc.v16.i3.137 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - April 5, 2024 Category: Cardiology Authors: Rupak Desai Ali Tariq Alvi Advait Vasavada Yashwitha Sai Pulakurthi Bhavin Patel Adil Sarvar Mohammed Shreyans Doshi Ikechukwu Ogbu Source Type: research

Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
CONCLUSION: Hepatic steatosis lowers the biochemical response to antiviral treatment in patients with CHB.PMID:38577526 | PMC:PMC10989305 | DOI:10.4254/wjh.v16.i3.465 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Shi-Yi Liu Dian Wang Jing Liu Lu-Ping Yang Gong-Ying Chen Source Type: research

Non-alcoholic fatty liver disease and sleep disorders
World J Hepatol. 2024 Mar 27;16(3):304-315. doi: 10.4254/wjh.v16.i3.304.ABSTRACTStudies have shown that non-alcoholic fatty liver disease (NAFLD) may be associated with sleep disorders. In order to explore the explicit relationship between the two, we systematically reviewed the effects of sleep disorders, especially obstructive sleep apnea (OSA), on the incidence of NAFLD, and analyzed the possible mechanisms after adjusting for confounding factors. NAFLD is independently associated with sleep disorders. Different sleep disorders may be the cause of the onset and aggravation of NAFLD. An excessive or insufficient sleep du...
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Lu-Fang Bu Chong-Yu Xiong Jie-Yi Zhong Yan Xiong Dong-Ming Li Fen-Fang Hong Shu-Long Yang Source Type: research

Update in lean metabolic dysfunction-associated steatotic liver disease
CONCLUSION: MASLD is a complex disease comprising epigenetic, genetic, and metabolic factors in its pathogenesis. Results vary across populations, gender, and age. Limited data exists on clinical practice guidelines for lean patients. Future studies employing this new nomenclature can contribute to standardizing and generalizing results among lean patients with steatotic liver disease.PMID:38577539 | PMC:PMC10989317 | DOI:10.4254/wjh.v16.i3.452 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Karina Sato-Espinoza Perapa Chotiprasidhi Mariella R Huaman Javier D íaz-Ferrer Source Type: research

Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019)
CONCLUSION: Increasing age and male sex link NAFLD with adverse MACCE outcomes; Native Americans and Asian Pacific Islanders face higher mortality, highlighting a need for tailored interventions and care.PMID:38576521 | PMC:PMC10989223 | DOI:10.4330/wjc.v16.i3.137 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - April 5, 2024 Category: Cardiology Authors: Rupak Desai Ali Tariq Alvi Advait Vasavada Yashwitha Sai Pulakurthi Bhavin Patel Adil Sarvar Mohammed Shreyans Doshi Ikechukwu Ogbu Source Type: research

Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
CONCLUSION: Hepatic steatosis lowers the biochemical response to antiviral treatment in patients with CHB.PMID:38577526 | PMC:PMC10989305 | DOI:10.4254/wjh.v16.i3.465 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Shi-Yi Liu Dian Wang Jing Liu Lu-Ping Yang Gong-Ying Chen Source Type: research

Non-alcoholic fatty liver disease and sleep disorders
World J Hepatol. 2024 Mar 27;16(3):304-315. doi: 10.4254/wjh.v16.i3.304.ABSTRACTStudies have shown that non-alcoholic fatty liver disease (NAFLD) may be associated with sleep disorders. In order to explore the explicit relationship between the two, we systematically reviewed the effects of sleep disorders, especially obstructive sleep apnea (OSA), on the incidence of NAFLD, and analyzed the possible mechanisms after adjusting for confounding factors. NAFLD is independently associated with sleep disorders. Different sleep disorders may be the cause of the onset and aggravation of NAFLD. An excessive or insufficient sleep du...
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Lu-Fang Bu Chong-Yu Xiong Jie-Yi Zhong Yan Xiong Dong-Ming Li Fen-Fang Hong Shu-Long Yang Source Type: research

Update in lean metabolic dysfunction-associated steatotic liver disease
CONCLUSION: MASLD is a complex disease comprising epigenetic, genetic, and metabolic factors in its pathogenesis. Results vary across populations, gender, and age. Limited data exists on clinical practice guidelines for lean patients. Future studies employing this new nomenclature can contribute to standardizing and generalizing results among lean patients with steatotic liver disease.PMID:38577539 | PMC:PMC10989317 | DOI:10.4254/wjh.v16.i3.452 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Karina Sato-Espinoza Perapa Chotiprasidhi Mariella R Huaman Javier D íaz-Ferrer Source Type: research

Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019)
CONCLUSION: Increasing age and male sex link NAFLD with adverse MACCE outcomes; Native Americans and Asian Pacific Islanders face higher mortality, highlighting a need for tailored interventions and care.PMID:38576521 | PMC:PMC10989223 | DOI:10.4330/wjc.v16.i3.137 (Source: World Journal of Cardiology)
Source: World Journal of Cardiology - April 5, 2024 Category: Cardiology Authors: Rupak Desai Ali Tariq Alvi Advait Vasavada Yashwitha Sai Pulakurthi Bhavin Patel Adil Sarvar Mohammed Shreyans Doshi Ikechukwu Ogbu Source Type: research

Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
CONCLUSION: Hepatic steatosis lowers the biochemical response to antiviral treatment in patients with CHB.PMID:38577526 | PMC:PMC10989305 | DOI:10.4254/wjh.v16.i3.465 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Shi-Yi Liu Dian Wang Jing Liu Lu-Ping Yang Gong-Ying Chen Source Type: research

Non-alcoholic fatty liver disease and sleep disorders
World J Hepatol. 2024 Mar 27;16(3):304-315. doi: 10.4254/wjh.v16.i3.304.ABSTRACTStudies have shown that non-alcoholic fatty liver disease (NAFLD) may be associated with sleep disorders. In order to explore the explicit relationship between the two, we systematically reviewed the effects of sleep disorders, especially obstructive sleep apnea (OSA), on the incidence of NAFLD, and analyzed the possible mechanisms after adjusting for confounding factors. NAFLD is independently associated with sleep disorders. Different sleep disorders may be the cause of the onset and aggravation of NAFLD. An excessive or insufficient sleep du...
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Lu-Fang Bu Chong-Yu Xiong Jie-Yi Zhong Yan Xiong Dong-Ming Li Fen-Fang Hong Shu-Long Yang Source Type: research

Update in lean metabolic dysfunction-associated steatotic liver disease
CONCLUSION: MASLD is a complex disease comprising epigenetic, genetic, and metabolic factors in its pathogenesis. Results vary across populations, gender, and age. Limited data exists on clinical practice guidelines for lean patients. Future studies employing this new nomenclature can contribute to standardizing and generalizing results among lean patients with steatotic liver disease.PMID:38577539 | PMC:PMC10989317 | DOI:10.4254/wjh.v16.i3.452 (Source: World Journal of Hepatology)
Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Karina Sato-Espinoza Perapa Chotiprasidhi Mariella R Huaman Javier D íaz-Ferrer Source Type: research